Article
EMA Accepts MAA For Dong-A ST's Ustekinumab Biosimilar
On July 14, Dong-A ST announced that the European Medicines Agency accepted its Marketing Authorization Application for DMB-3115, a biosimilar referencing STELARA.
Goodwin Procter LLP
Use advanced search filters to refine your search